Grant: Alliance Grants
Université de Sherbrooke
$25,000.00
Electrochemical Aptamer-Based Biosensors for Salivary Molecular Measurements
FY 2021-22
Summary
Developing a device amenable to the point-of-care for the measurement of the concentrations of specific biomarkers that are inherent to the onset of gingivitis would transform how this disease is currently diagnosed in the clinic. This technology would, likewise, allow patients to remain connected to their oral health within the comfort of their homes in an analogous fashion to the glucometer. In response, we propose here, with the collaboration of our industrial partner, to evaluate the ability of electrochemical aptamer-based biosensors to readily deploy in undiluted saliva, a non-invasive matrix to monitor patients' health and measure inherent biomarkers of interest associated with this disease. Electrochemical aptamer-based biosensors have demonstrated unprecedented abilities in performing real-time, continuous, single-step and reagentless measurements of a wide range of molecules directly in undiluted complex matrices, like whole blood, and even directly in the living body. Unfortunately, no viability studies toward their ability to readily deploy in undiluted saliva have been completed, which in turn, limits their applicability in the clinic and at the point-of-care. Considering that electrochemical aptamer-based biosensors can detect virtually any target of interest, via the simple expedient of changing the aptamer, they could prove transformative in an oral health setting to help providers identify risks and optimize prevention. This proposal is for securing the necessary funds to undertake a proof-of-concept study of model systems electrochemical aptamer-based biosensors deployed in undiluted saliva to evaluate its impact on the analytical performance of this sensing platform and evaluate the need to develop drift and calibration strategies. We envision that this viability study will prove essential in the pursuit of a convenient and generalizable sensing platform to improve oral health.
Program
Alliance Grants
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
566687-2021
Name nom
Dauphin Ducharme, Philippe
Department département
Chimie
Organization id
68
Institution établissement
Université de Sherbrooke
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2021
Competition year année de concours
2021
Award amount
25000
Program id
ALLRP
Program name en
Alliance Grants
Program name fr
Subventions Alliance
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
96
Committee name en
RPP Internal Decision Cttee
Committee name fr
Cté de décision interne - PPR
Area of application code
1211
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Medical and health sciences
Area of application fr
Sciences médicales et de la santé
Research subject code
3504
Research subject group en
Analytical chemistry
Research subject group fr
Chimie analytique
Research subject en
Bioanalytical chemistry
Research subject fr
Chimie bioanalytique
Installment
inst:1
Partie
1
Nb partie
1
Application title
Electrochemical Aptamer-Based Biosensors for Salivary Molecular Measurements
Keyword
NSERC
Application summary
Developing a device amenable to the point-of-care for the measurement of the concentrations of specific biomarkers that are inherent to the onset of gingivitis would transform how this disease is currently diagnosed in the clinic. This technology would, likewise, allow patients to remain connected to their oral health within the comfort of their homes in an analogous fashion to the glucometer. In response, we propose here, with the collaboration of our industrial partner, to evaluate the ability of electrochemical aptamer-based biosensors to readily deploy in undiluted saliva, a non-invasive matrix to monitor patients' health and measure inherent biomarkers of interest associated with this disease. Electrochemical aptamer-based biosensors have demonstrated unprecedented abilities in performing real-time, continuous, single-step and reagentless measurements of a wide range of molecules directly in undiluted complex matrices, like whole blood, and even directly in the living body. Unfortunately, no viability studies toward their ability to readily deploy in undiluted saliva have been completed, which in turn, limits their applicability in the clinic and at the point-of-care. Considering that electrochemical aptamer-based biosensors can detect virtually any target of interest, via the simple expedient of changing the aptamer, they could prove transformative in an oral health setting to help providers identify risks and optimize prevention. This proposal is for securing the necessary funds to undertake a proof-of-concept study of model systems electrochemical aptamer-based biosensors deployed in undiluted saliva to evaluate its impact on the analytical performance of this sensing platform and evaluate the need to develop drift and calibration strategies. We envision that this viability study will prove essential in the pursuit of a convenient and generalizable sensing platform to improve oral health.